How CRISPR gene editing will treat diseases in future: Nobel-winning Intellia co-founder Jennifer Doudna
June 30, 2021 at 10:04 AM EDT
Jennifer Doudna, 2020 Nobel Prize winner in chemistry for CRISPR gene editing and co-founder of Intellia Therapeutics, on future of the breakthrough technology.
